Skip to main content

Advertisement

Log in

Antiviral Properties of the New Coordination Compound Silver Bis(Citrato)Germanate

  • Published:
Pharmaceutical Chemistry Journal Aims and scope

The new coordination polymer silver bis(citrato)germanate was synthesized and exhibited pronounced antiviral activity against human influenza virus strains A/Hong Kong/1/68 (H3N2) and A/Puerto Rico/34 (H1N1). Its effective dose was five times lower than that of the reference drug oseltamivir, which made this compound promising for further studies in animal models.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Similar content being viewed by others

References

  1. N. A. Shkil’, V. A. Burmistrov, and M. Yu. Sokolov, Nauchn. Zh. KubGAU, 68(04), (2011).

  2. I. S. Chezhman, Nauka Innovatsii, 11(1), 72 – 77 (2015); doi: http: // dx.doi.org / 10.15407 / scin11.01.072.

  3. L. G. Menchikov and M. A. Ignatenko, Khim.-farm. Zh., 46(11), 3 – 6 (2012); Pharm. Chem. J., 46(11), 635 – 638 (2013).

  4. WHO Guidelines for Pharmacological Management of Pandemic (H1N1) 2009 Influenza and Other Influenza Viruses; http: // www.who.int / csr / resources / publications / swineflu / h1n1 use antivirals 20090820 / en / index.html

  5. T. L. Gridina, Odess. Med. Zh., 151(5), 76 – 80 (2015).

    Google Scholar 

  6. L. V. Gubareva and F. G. Hayden, Influenza Virology: Current Topics, Caister Press,Wymondham, U. K., 2006, pp. 169 – 202.

  7. Center of Diesis Control and Prevention. Oseltamivir-resistant 2009 pandemic influenza A (H1N1) virus infection in two summer campers receiving prophylaxis, MMWR Morb. Mortal. Wkly. Rep., 58, 969 – 972 (2009).

  8. T. A. Mikhas’ko, B. V. Dubovik, O. I. Shadyro, et al., Med. Nov., 4, 81 (2012).

    Google Scholar 

  9. I. Seifullina, E. Martsinko, E. Chebanenko, et al., Program and Abstracts of the 29 th International Conference on Antiviral Research, La Jolla, 2016, Abstr. 165; http: // c.ymcdn.com / sites / www.isar-icar.com / resource / resmgr / ISAR_Program2016_webApril11.pdf [https: // www.isar-icar.com / resources / Documents / ISAR Program2016 webApril11.pdf]

  10. V. S. Sergienko, E. E. Martsinko, I. I. Seifullina, et al., Crystallogr. Rep., 61(2), 203 – 208 (2016).

    Article  CAS  Google Scholar 

  11. A. V. Stefanov (ed.), Preclinical Drug Trials, Methodical Recommendations [in Russian], Avitsenna, Kiev, 2002.

  12. B. W. J. Mahy (ed.), Virology, IRL Press, Oxford, 1985.

  13. I. P. Ashmarin, Zh. Mikrobiol., No. 2, 102 – 108 (1959).

  14. E. V. Gubler and A. A. Genkin, Application of Nonparametric Criteria of Statistics to Medical and Biological Studies [in Russian], Meditsina, Leningrad, 1973.

Download references

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to T. L. Gridina.

Additional information

Translated from Khimiko-Farmatsevticheskii Zhurnal, Vol. 53, No. 4, pp. 10 – 10, April, 2019.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Seifullina, I.I., Martsinko, E.É., Gridina, T.L. et al. Antiviral Properties of the New Coordination Compound Silver Bis(Citrato)Germanate. Pharm Chem J 53, 318–321 (2019). https://doi.org/10.1007/s11094-019-01999-w

Download citation

  • Received:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s11094-019-01999-w

Keywords

Navigation